204 related articles for article (PubMed ID: 33386701)
1. Development and validation of a four-lipid metabolism gene signature for diagnosis of pancreatic cancer.
Ye Y; Chen Z; Shen Y; Qin Y; Wang H
FEBS Open Bio; 2021 Nov; 11(11):3153-3170. PubMed ID: 33386701
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
Wang F; Chen C; Chen WP; Li ZL; Cheng H
Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
[TBL] [Abstract][Full Text] [Related]
3. Integrated miRNA-mRNA Expression Profiles Revealing Key Molecules in Ovarian Cancer Based on Bioinformatics Analysis.
Li C; Hong Z; Ou M; Zhu X; Zhang L; Yang X
Biomed Res Int; 2021; 2021():6673655. PubMed ID: 34734085
[TBL] [Abstract][Full Text] [Related]
4. Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis.
You L; Wang J; Zhang F; Zhang J; Tao H; Zheng X; Hu Y
Mol Med Rep; 2019 Jan; 19(1):441-451. PubMed ID: 30483731
[TBL] [Abstract][Full Text] [Related]
5. A 6‑gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients.
Liu Y; Zhu D; Xing H; Hou Y; Sun Y
Oncol Rep; 2019 Mar; 41(3):1521-1530. PubMed ID: 30747226
[TBL] [Abstract][Full Text] [Related]
6. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
Mo S; Pei Z; Dai L
Genet Test Mol Biomarkers; 2021 Mar; 25(3):163-178. PubMed ID: 33734891
[No Abstract] [Full Text] [Related]
7. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
[TBL] [Abstract][Full Text] [Related]
8. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
9. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
Yang ZQ; Liu YJ; Zhou XL
Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
[TBL] [Abstract][Full Text] [Related]
10. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
[TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
12. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
13. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
Huang Z; Yang Q; Huang Z
Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
15. The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction.
Tan Z; Lei Y; Xu J; Shi S; Hua J; Zhang B; Meng Q; Liu J; Zhang Y; Wei M; Yu X; Liang C
Aging (Albany NY); 2020 Nov; 12(23):24228-24241. PubMed ID: 33226369
[TBL] [Abstract][Full Text] [Related]
16. A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme.
Zhao J; Wang L; Hu G; Wei B
Biomed Res Int; 2019; 2019():1649423. PubMed ID: 31531345
[TBL] [Abstract][Full Text] [Related]
17. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
18. Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma.
Li J; Li Q; Su Z; Sun Q; Zhao Y; Feng T; Jiang J; Zhang F; Ma H
Lipids Health Dis; 2020 Oct; 19(1):222. PubMed ID: 33050938
[TBL] [Abstract][Full Text] [Related]
19. A 65‑gene signature for prognostic prediction in colon adenocarcinoma.
Jiang H; Du J; Gu J; Jin L; Pu Y; Fei B
Int J Mol Med; 2018 Apr; 41(4):2021-2027. PubMed ID: 29393333
[TBL] [Abstract][Full Text] [Related]
20. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
